The Valley Desk

NCT05031780 · Interventional trial

A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)

Overall registry status Active not recruiting

Phase 2 · Phase 3

Conditions Sickle Cell Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov